UNH vs GILD
By Alex · Tickerpine
UnitedHealth Group Incorporated vs Gilead Sciences, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | UNH | GILD |
|---|---|---|
| Price | $376.59 | $150.93 |
| Market cap | $338.03B | $187.15B |
| P/E ratio | 24.2 | — |
| ROE | 14.15% | -20.68% |
| Profit margin | 3.14% | -10.64% |
| Revenue growth | 0.40% | 10.20% |
| Dividend yield | 2.46% | 2.17% |
| Beta | 0.62 | 0.35 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
UNH vs GILD in plain English
- UNH is the bigger company — about 1.8× the market cap of GILD.
- UNH earns a higher return on equity (14% vs -21%).
- GILD is growing revenue faster (10% vs 0%).
- UNH has the higher dividend yield (2.46% vs 2.17%).
How would $1,000 have done in each?
UNH return calculator
See what $1,000 in UnitedHealth Group Incorporated would be worth today.
GILD return calculator
See what $1,000 in Gilead Sciences, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.